ALYACEN 777

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

28 API Suppliers, 15 USDMF, 7 CEP/COS, 3 JDMF, 5 EU WC, 7 NDC API, 13 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Formulations

174 Dossiers, 116 FDA Orange Book, 19 Europe, 13 Canada, 2 Australia, 16 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL-28 - 0.05MG;1MG, TABLET;ORAL-28 - 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.35MG, TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

TABLET;ORAL-28 - 0.05MG;1MG
TABLET;ORAL-28 - 0.35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.35MG
TABLET;ORAL-28 - 0.035MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 0.025MG;0.8MG

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 17 Roquette, 13 Microlex e.U, 12 BASF, 11 Sigachi Industries, 11 Corel Pharma Chem, 8 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 Lonza Capsugel, 6 Boai NKY Pharmaceuticals Ltd, 6 DFE Pharma, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 4 Kima Chemical, 4 SPI Pharma, 3 Ulanqab Kema New Material, 3 Pharmatrans-Sanaq, 3 Ingredion Pharma Solutions, 3 Prachin Chemical, 3 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 DKSH, 1 Aeon Procare, 1 Huzhou Sunflower Pharmaceutical Co. Ltd, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 31 Direct Compression, 27 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 22 Granulation, 16 Thickeners and Stabilizers, 15 Film Formers & Plasticizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 11 Solubilizers, 10 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Parenteral, 2 Coloring Agents, 2 Rheology Modifiers